Chengdu Kanghong Pharmaceutical Group Co., Ltd.

This early-stage trial tests a new oral drug called KHN702 for moderate to severe pain after surgery. About 24 adults will receive either the drug or a placebo to see if it is safe and helps reduce pain. The study is double-blind, meaning neither patients nor doctors know who get…

This study looks at how a high-fat meal changes the way KH607 tablets are absorbed in the body. Sixteen healthy Chinese adults will take the drug once on an empty stomach and once after a fatty meal to compare the effects. The goal is to understand food's impact on the drug and c…

This early-stage study tests whether KHN707 tablets are safe and how the body processes them. About 38 healthy Chinese adults aged 18-45 will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease…